Anti-MEF2C Recombinant Antibody, IgG1, Clone: [CL0368], Mouse, Monoclonal

Produktübersicht

• Artikelname: Anti-MEF2C Recombinant Antibody, IgG1, Clone: [CL0368], Mouse, Monoclonal
• Artikelnummer: ATA-AMAB90727R
• Hersteller Artikelnummer: AMAb90727R
• Alternativnummer: ATA-AMAB90727R-100, ATA-AMAB90727R-25
• Hersteller: Atlas Antibodies
• Wirt: Mouse
• Kategorie: Antikörper
• Applikation: ICC, IHC, WB
• Spezies Reaktivität: Human

Produktbeschreibung

Recombinant Mouse Monoclonal Anti-MEF2C Antibody against Human myocyte enhancer factor 2C. Validated for Immunofluorescence, Immunohistochemistry and Western Blot

Produkteigenschaften

• Klonalität: Monoclonal
• Konzentration: 1
• Klon-Bezeichnung: [CL0368]
• Isotyp: IgG1
• NCBI: 4208
• UniProt: Q06413
• Puffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.

Bilder

Lane 1: Marker [kDa]
Lane 2: Negative control (vector only transfected HEK293T lysate)
Lane 3: MEF2C Over-expression Lysate (Co-expressed with a C-terminal myc-DDK tag (~3.1 kDa) in mammalian HEK293T cells, LY419349)

Immunohistochemical staining of human cerebellum shows strong nuclear positivity in Purkinje cells.

Immunohistochemical staining of human cerebral cortex shows strong immunoreactivity in neuronal cells.

Immunofluorescence staining of RH-30 cells using the Anti-MEF2C monoclonal antibody, showing specific staining in the nucleoplasm in green. Microtubule- and nuclear probes are visualized in red and blue, respectively (where available).

Immunohistochemical staining of human skeletal muscle shows moderate nuclear positivity in muscle fibers.

Immunohistochemical staining of human pancreas shows absense of staining (negative control).

Immunohistochemical staining of human duodenum shows strong nuclear immunoreactivity in a subset of lymphoid cells.

Immunohistochemical staining of human tonsil shows strong nuclear immunoreactivity in a subset of lymphoid cells.

Western blot analysis in WM115 cells transfected with control siRNA, target specific siRNA probe 1 and 2, using Anti-MEF2C antibody. Remaining relative intensity is presented. Loading control: Anti-GAPDH.